HIND
What one share of Vyome Holdings holds
Pharmaceutical Preparations
Lifesciences Inc. (now known as Vyome Holdings, Inc.) (the “Company”) completed the merger pursuant to the Agreement and Plan
Vyome Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.02 |
|---|---|
| Profit | −$2.14 |
| Cash and investments | $1.12 |
| Book value | $1.04 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | — | −$1,040 | $31.20 | −$947.14 | — | $1,003 |
| 2018 | — | −$981.75 | $33.67 | −$806.68 | — | $281.45 |
| 2019 | — | −$251.51 | $2.06 | −$244.97 | — | $156.05 |
| 2020 | — | −$277.44 | $2.19 | −$111.86 | — | $207.79 |
| 2021 | — | −$288.97 | $1.61 | −$71.97 | — | $124.31 |
| 2022 | — | −$108.90 | $0.31 | −$51.92 | — | $7.05 |
| 2023 | — | −$110.87 | $0.42 | −$165.55 | — | — |
| 2025 | $0.15 | −$4.75 | — | −$1.73 | — | $0.64 |